Enzon Pharmaceuticals, Inc. ENZN

ENZN

Enzon Pharmaceuticals, Inc.

Exchange: nyse

Multiples

P/E:
P/BV: 4.05
P/TBV: 3.18

Description:

none

Data:

Market Cap

11132190.00

EBITDA

Net Income

Yields:

Earnings Yield

Return on Capital

CAGR (net income)

14.72%

CAGR Length

0.75

Dividend Rate